Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
127.21
+0.87 (0.69%)
At close: Mar 24, 2025, 4:00 PM
127.50
+0.29 (0.23%)
After-hours: Mar 24, 2025, 7:40 PM EST
Abbott Laboratories Employees
Abbott Laboratories had 114,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
114,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$367,982
Profits / Employee
$117,114
Market Cap
220.62B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 114,000 | 0 | - |
Dec 31, 2023 | 114,000 | -1,000 | -0.87% |
Dec 31, 2022 | 115,000 | 2,000 | 1.77% |
Dec 31, 2021 | 113,000 | 4,000 | 3.67% |
Dec 31, 2020 | 109,000 | 2,000 | 1.87% |
Dec 31, 2019 | 107,000 | 4,000 | 3.88% |
Dec 31, 2018 | 103,000 | 4,000 | 4.04% |
Dec 31, 2017 | 99,000 | 24,000 | 32.00% |
Dec 31, 2016 | 75,000 | 1,000 | 1.35% |
Dec 31, 2015 | 74,000 | -3,000 | -3.90% |
Dec 31, 2014 | 77,000 | 8,000 | 11.59% |
Dec 31, 2013 | 69,000 | -22,000 | -24.18% |
Dec 31, 2012 | 91,000 | 0 | - |
Dec 31, 2011 | 91,000 | 1,000 | 1.11% |
Dec 31, 2010 | 90,000 | 17,000 | 23.29% |
Dec 31, 2009 | 73,000 | 4,000 | 5.80% |
Dec 31, 2008 | 69,000 | 1,000 | 1.47% |
Dec 31, 2007 | 68,000 | 1,337 | 2.01% |
Dec 31, 2006 | 66,663 | 6,928 | 11.60% |
Dec 31, 2005 | 59,735 | -865 | -1.43% |
Dec 31, 2004 | 60,600 | -11,600 | -16.07% |
Dec 31, 2003 | 72,200 | 381 | 0.53% |
Dec 31, 2002 | 71,819 | 393 | 0.55% |
Dec 31, 2001 | 71,426 | 10,855 | 17.92% |
Dec 31, 2000 | 60,571 | 3,471 | 6.08% |
Dec 31, 1999 | 57,100 | 864 | 1.54% |
Dec 31, 1998 | 56,236 | 1,749 | 3.21% |
Dec 31, 1997 | 54,487 | 1,670 | 3.16% |
Dec 31, 1996 | 52,817 | 2,576 | 5.13% |
Dec 31, 1995 | 50,241 | 777 | 1.57% |
Dec 31, 1994 | 49,464 | -195 | -0.39% |
Dec 31, 1993 | 49,659 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ABT News
- 1 day ago - Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease - PRNewsWire
- 3 days ago - 2025 Dividend Kings: Strong Run Continues - Seeking Alpha
- 8 days ago - Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees - Seeking Alpha
- 18 days ago - Strong Earnings Lift Abbott Laboratories Shares - FXEmpire
- 19 days ago - The Dividend Aristocrats Ranked By Quality Scores: March 2025 - Seeking Alpha
- 20 days ago - Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion - Business Wire
- 21 days ago - Cadrenal Therapeutics Announces Collaboration Agreement with Abbott in Support of Pivotal Study of Tecarfarin in Patients with HeartMate 3™ LVAD - Business Wire
- 25 days ago - My Best Dividend Aristocrats For March 2025 - Seeking Alpha